About: Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Cyclosarin is one member of nerve agents´ family. Recent treatment of intoxications by organophosphorus compounds, such as nerve agents or pesticides, consists of rapid administration of anticholinergics and AChE reactivators. Owing to the threat of terroristic use of these compounds during last years, improvement of antidotal therapy still continues. As the part of the development of new antidotes, many new AChE reactivators were synthesized and currently some of them are under consideration for introducing them to the medical praxis. Their biological activity depends, as in the case of other drugs, on their chemical structure, which affects their pharmacokinetic (adsorption, distribution, metabolism and excretion) and pharmacodynamics. In this review, we would like to discuss relationship between structure of currently available AChE reactivators and their potency to reactivate cyclosarin-inhibited AChE. All outlined structural factors presented in this work should be helpful for the design of new
  • Cyclosarin is one member of nerve agents´ family. Recent treatment of intoxications by organophosphorus compounds, such as nerve agents or pesticides, consists of rapid administration of anticholinergics and AChE reactivators. Owing to the threat of terroristic use of these compounds during last years, improvement of antidotal therapy still continues. As the part of the development of new antidotes, many new AChE reactivators were synthesized and currently some of them are under consideration for introducing them to the medical praxis. Their biological activity depends, as in the case of other drugs, on their chemical structure, which affects their pharmacokinetic (adsorption, distribution, metabolism and excretion) and pharmacodynamics. In this review, we would like to discuss relationship between structure of currently available AChE reactivators and their potency to reactivate cyclosarin-inhibited AChE. All outlined structural factors presented in this work should be helpful for the design of new (en)
  • Strukturní faktory ovlivňující schopnost v současnosti užívaných reaktivátorů AChE léčit cyklosarinové intoxikace. (cs)
Title
  • Strukturní faktory ovlivňující schopnost v současnosti užívaných reaktivátorů AChE léčit cyklosarinové intoxikace (cs)
  • Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications
  • Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications (en)
skos:prefLabel
  • Strukturní faktory ovlivňující schopnost v současnosti užívaných reaktivátorů AChE léčit cyklosarinové intoxikace (cs)
  • Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications
  • Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications (en)
skos:notation
  • RIV/60162694:G44__/07:00001809!RIV09-GA0-G44_____
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(GP305/07/P162)
http://linked.open...iv/cisloPeriodika
  • 33
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 452860
http://linked.open...ai/riv/idVysledku
  • RIV/60162694:G44__/07:00001809
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Acetylcholinesterase; nerve agent; antidotes; cyclosarin; reactivators; oxime (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • AE - Stát Spojené arabské emiráty
http://linked.open...ontrolniKodProRIV
  • [944234A38792]
http://linked.open...i/riv/nazevZdroje
  • Current Pharmaceutical Design
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 13
http://linked.open...iv/tvurceVysledku
  • Bajgar, Jiří
  • Kuča, Kamil
  • Jun, Daniel
issn
  • 1381-6128
number of pages
http://localhost/t...ganizacniJednotka
  • G44
Faceted Search & Find service v1.16.116 as of Feb 22 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of Feb 22 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 82 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software